Concepedia

Marissa Shrader

MS

Statistics

Publications

10

Citations

718

H-Index

10

Active since

1995

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Marissa Shrader is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

1995–2010

10

Publications

10

Effect of the vascular endothelial growth factor receptor‐2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice

Christiane J. Bruns, Marissa Shrader, Matthew T. Harbison et al. · International Journal of Cancer · 2002 · 143 citations

, , +17

Bortezomib Abolishes Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance via a p21-Dependent Mechanism in Human Bladder and Prostate Cancer Cells

Laura M. Lashinger, Keyi Zhu, Simon A. Williams et al. · Cancer Research · 2005 · 109 citations · Full text

, , +17

Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells

Peter C. Black, Gordon Brown, Teruo Inamoto et al. · Clinical Cancer Research · 2008 · 107 citations

, , +17

Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.

M. Scott Lucia, Mario A. Anzano, M. V. Slayter et al. · PubMed · 1995 · 96 citations

, , +16

Gefitinib Reverses TRAIL Resistance in Human Bladder Cancer Cell Lines via Inhibition of AKT-Mediated X-Linked Inhibitor of Apoptosis Protein Expression

Marissa Shrader, Maria Simona Pino, Laura M. Lashinger et al. · Cancer Research · 2007 · 84 citations

, , +17

1–5 of 10